Close

Drug Injury Lawyers Blog

Updated:

$100M NuvaRing Injury Settlement Now Final

Now that 95% of eligible plaintiffs have opted in, the $100 million defective medical device settlement between NuvaRing manufacturer Merck & Co. and 3,800 claimants will stand. A district court judge had approved the birth control injury settlement earlier this year. Merck, however, could have backed out of the agreement…

Updated:

Parents, Doctors Warn of Prescribing Adderall to Toddlers

Attention Deficit Disorder, or ADD (ADHD in some children includes hyperactivity) generally becomes evident when children and young adults are in school and start to experience difficulties in class or concentrating on homework. Diagnosis and treatment of this complex disorder is extremely difficult, and there has been heated debate on…

Updated:

Widow’s Drug Defect Lawsuit Claims Generic Paxil Prompted Her Husband’s Suicide

In an unexpected ruling, the Seventh Circuit Court of Appeals has denied GlaxoSmithKline PLC’s motion to dismiss a drug defect lawsuit blaming the pharmaceutical company for a man’s suicide. The wrongful death case, filed by the widow of Stewart Dolin, contends that it was the six paroxetine tablets, which he…

Updated:

German Drug Maker Agrees to Pay $650M to Settle Pradaxa Claims

German pharmaceutical company Boehringer Ingelheim has agreed to pay $650 million to settle thousands of consumer lawsuits involving its blood thinner medication Pradaxa. The company issued a statement Wednesday to publicize its agreement, which will most likely settle the majority of the 4,000 cases brought against the company by patients…

Updated:

Boehringer Ingelheim Settles Over 4,000 Pradaxa Drug Injury Lawsuits for $650M

Boehringer Ingelheim says that it will pay $650 million to resolve more than 4,000 drug defect cases involving Pradaxa, its anticoagulant. Despite settling, the drug manufacturer is denying any wrongdoing. Pradaxa has been named in numerous incidents involving excessive bleeding complications. The U.S. Food and Drug Administration has received notice…

Updated:

Jury Awards $1.59 Million to Accutane Victim with Ulcerative Colitis

A New Jersey jury recently awarded a substantial $1.59 million verdict to a victim who was prescribed the acne drug Accutane and developed Ulcerative Colitis. The jury found that Hoffman-LaRoche and Roche Laboratories, which manufactures Accutane “failed to provide Kamie Kendall Ries…with adequate warning of the health risks.” Ries’ winning…

Contact Us
Start Chat